The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Targeted Therapy for Breast Cancer Market Research Report 2025
Synopsis
Breast cancer is a disease in which cells in the breast grow out of control. There are different kinds of breast cancer.
The global Targeted Therapy for Breast Cancer market was valued at US$ 5948 million in 2023 and is anticipated to reach US$ 11780 million by 2030, witnessing a CAGR of 10.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Targeted Therapy for Breast Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Therapy for Breast Cancer.
Report Scope
The Targeted Therapy for Breast Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Therapy for Breast Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Therapy for Breast Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Roche
Merck & Co.
Novartis
Pfizer
Merck KGaA
Astellas
Janssen Biotech
Bristol-Myers Squibb
Gilead Sciences
Segment by Type
Brand Drugs
Generic Drug
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Therapy for Breast Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Breast cancer is a disease in which cells in the breast grow out of control. There are different kinds of breast cancer.
The global Targeted Therapy for Breast Cancer market was valued at US$ 5948 million in 2023 and is anticipated to reach US$ 11780 million by 2030, witnessing a CAGR of 10.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Targeted Therapy for Breast Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Therapy for Breast Cancer.
Report Scope
The Targeted Therapy for Breast Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Therapy for Breast Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Therapy for Breast Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Roche
Merck & Co.
Novartis
Pfizer
Merck KGaA
Astellas
Janssen Biotech
Bristol-Myers Squibb
Gilead Sciences
Segment by Type
Brand Drugs
Generic Drug
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Therapy for Breast Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Therapy for Breast Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Targeted Therapy for Breast Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Therapy for Breast Cancer Market Perspective (2019-2030)
2.2 Targeted Therapy for Breast Cancer Growth Trends by Region
2.2.1 Global Targeted Therapy for Breast Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted Therapy for Breast Cancer Historic Market Size by Region (2019-2024)
2.2.3 Targeted Therapy for Breast Cancer Forecasted Market Size by Region (2025-2030)
2.3 Targeted Therapy for Breast Cancer Market Dynamics
2.3.1 Targeted Therapy for Breast Cancer Industry Trends
2.3.2 Targeted Therapy for Breast Cancer Market Drivers
2.3.3 Targeted Therapy for Breast Cancer Market Challenges
2.3.4 Targeted Therapy for Breast Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Therapy for Breast Cancer Players by Revenue
3.1.1 Global Top Targeted Therapy for Breast Cancer Players by Revenue (2019-2024)
3.1.2 Global Targeted Therapy for Breast Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Therapy for Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Therapy for Breast Cancer Revenue
3.4 Global Targeted Therapy for Breast Cancer Market Concentration Ratio
3.4.1 Global Targeted Therapy for Breast Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Therapy for Breast Cancer Revenue in 2023
3.5 Targeted Therapy for Breast Cancer Key Players Head office and Area Served
3.6 Key Players Targeted Therapy for Breast Cancer Product Solution and Service
3.7 Date of Enter into Targeted Therapy for Breast Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Therapy for Breast Cancer Breakdown Data by Type
4.1 Global Targeted Therapy for Breast Cancer Historic Market Size by Type (2019-2024)
4.2 Global Targeted Therapy for Breast Cancer Forecasted Market Size by Type (2025-2030)
5 Targeted Therapy for Breast Cancer Breakdown Data by Application
5.1 Global Targeted Therapy for Breast Cancer Historic Market Size by Application (2019-2024)
5.2 Global Targeted Therapy for Breast Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted Therapy for Breast Cancer Market Size (2019-2030)
6.2 North America Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted Therapy for Breast Cancer Market Size by Country (2019-2024)
6.4 North America Targeted Therapy for Breast Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Therapy for Breast Cancer Market Size (2019-2030)
7.2 Europe Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted Therapy for Breast Cancer Market Size by Country (2019-2024)
7.4 Europe Targeted Therapy for Breast Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Therapy for Breast Cancer Market Size (2019-2030)
8.2 Asia-Pacific Targeted Therapy for Breast Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Therapy for Breast Cancer Market Size (2019-2030)
9.2 Latin America Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted Therapy for Breast Cancer Market Size by Country (2019-2024)
9.4 Latin America Targeted Therapy for Breast Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Therapy for Breast Cancer Market Size (2019-2030)
10.2 Middle East & Africa Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Introduction
11.1.4 Eli Lilly and Company Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Targeted Therapy for Breast Cancer Introduction
11.2.4 Roche Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Targeted Therapy for Breast Cancer Introduction
11.3.4 Merck & Co. Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.3.5 Merck & Co. Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Targeted Therapy for Breast Cancer Introduction
11.4.4 Novartis Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Targeted Therapy for Breast Cancer Introduction
11.5.4 Pfizer Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Targeted Therapy for Breast Cancer Introduction
11.6.4 Merck KGaA Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.6.5 Merck KGaA Recent Development
11.7 Astellas
11.7.1 Astellas Company Detail
11.7.2 Astellas Business Overview
11.7.3 Astellas Targeted Therapy for Breast Cancer Introduction
11.7.4 Astellas Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.7.5 Astellas Recent Development
11.8 Janssen Biotech
11.8.1 Janssen Biotech Company Detail
11.8.2 Janssen Biotech Business Overview
11.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Introduction
11.8.4 Janssen Biotech Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.8.5 Janssen Biotech Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Introduction
11.9.4 Bristol-Myers Squibb Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Detail
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Introduction
11.10.4 Gilead Sciences Revenue in Targeted Therapy for Breast Cancer Business (2019-2024)
11.10.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Targeted Therapy for Breast Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Targeted Therapy for Breast Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Targeted Therapy for Breast Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Targeted Therapy for Breast Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Targeted Therapy for Breast Cancer Market Share by Region (2019-2024)
Table 8. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Targeted Therapy for Breast Cancer Market Share by Region (2025-2030)
Table 10. Targeted Therapy for Breast Cancer Market Trends
Table 11. Targeted Therapy for Breast Cancer Market Drivers
Table 12. Targeted Therapy for Breast Cancer Market Challenges
Table 13. Targeted Therapy for Breast Cancer Market Restraints
Table 14. Global Targeted Therapy for Breast Cancer Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Targeted Therapy for Breast Cancer Market Share by Players (2019-2024)
Table 16. Global Top Targeted Therapy for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Breast Cancer as of 2023)
Table 17. Ranking of Global Top Targeted Therapy for Breast Cancer Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Targeted Therapy for Breast Cancer Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Targeted Therapy for Breast Cancer Product Solution and Service
Table 21. Date of Enter into Targeted Therapy for Breast Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Therapy for Breast Cancer Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Targeted Therapy for Breast Cancer Revenue Market Share by Type (2019-2024)
Table 25. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Targeted Therapy for Breast Cancer Revenue Market Share by Type (2025-2030)
Table 27. Global Targeted Therapy for Breast Cancer Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Targeted Therapy for Breast Cancer Revenue Market Share by Application (2019-2024)
Table 29. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Targeted Therapy for Breast Cancer Revenue Market Share by Application (2025-2030)
Table 31. North America Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Targeted Therapy for Breast Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Targeted Therapy for Breast Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Targeted Therapy for Breast Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Targeted Therapy for Breast Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Targeted Therapy for Breast Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Targeted Therapy for Breast Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Targeted Therapy for Breast Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 46. Eli Lilly and Company Company Detail
Table 47. Eli Lilly and Company Business Overview
Table 48. Eli Lilly and Company Targeted Therapy for Breast Cancer Product
Table 49. Eli Lilly and Company Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 50. Eli Lilly and Company Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Targeted Therapy for Breast Cancer Product
Table 54. Roche Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Merck & Co. Company Detail
Table 57. Merck & Co. Business Overview
Table 58. Merck & Co. Targeted Therapy for Breast Cancer Product
Table 59. Merck & Co. Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 60. Merck & Co. Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Targeted Therapy for Breast Cancer Product
Table 64. Novartis Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Targeted Therapy for Breast Cancer Product
Table 69. Pfizer Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Merck KGaA Company Detail
Table 72. Merck KGaA Business Overview
Table 73. Merck KGaA Targeted Therapy for Breast Cancer Product
Table 74. Merck KGaA Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 75. Merck KGaA Recent Development
Table 76. Astellas Company Detail
Table 77. Astellas Business Overview
Table 78. Astellas Targeted Therapy for Breast Cancer Product
Table 79. Astellas Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 80. Astellas Recent Development
Table 81. Janssen Biotech Company Detail
Table 82. Janssen Biotech Business Overview
Table 83. Janssen Biotech Targeted Therapy for Breast Cancer Product
Table 84. Janssen Biotech Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 85. Janssen Biotech Recent Development
Table 86. Bristol-Myers Squibb Company Detail
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Product
Table 89. Bristol-Myers Squibb Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Gilead Sciences Company Detail
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Targeted Therapy for Breast Cancer Product
Table 94. Gilead Sciences Revenue in Targeted Therapy for Breast Cancer Business (2019-2024) & (US$ Million)
Table 95. Gilead Sciences Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Therapy for Breast Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Targeted Therapy for Breast Cancer Market Share by Type: 2023 VS 2030
Figure 3. Brand Drugs Features
Figure 4. Generic Drug Features
Figure 5. Global Targeted Therapy for Breast Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Targeted Therapy for Breast Cancer Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Targeted Therapy for Breast Cancer Report Years Considered
Figure 11. Global Targeted Therapy for Breast Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Targeted Therapy for Breast Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Targeted Therapy for Breast Cancer Market Share by Region: 2023 VS 2030
Figure 14. Global Targeted Therapy for Breast Cancer Market Share by Players in 2023
Figure 15. Global Top Targeted Therapy for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Breast Cancer as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Targeted Therapy for Breast Cancer Revenue in 2023
Figure 17. North America Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Targeted Therapy for Breast Cancer Market Share by Country (2019-2030)
Figure 19. United States Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Targeted Therapy for Breast Cancer Market Share by Country (2019-2030)
Figure 23. Germany Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Targeted Therapy for Breast Cancer Market Share by Region (2019-2030)
Figure 31. China Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Targeted Therapy for Breast Cancer Market Share by Country (2019-2030)
Figure 39. Mexico Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Targeted Therapy for Breast Cancer Market Share by Country (2019-2030)
Figure 43. Turkey Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Targeted Therapy for Breast Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Eli Lilly and Company Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 47. Merck & Co. Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 50. Merck KGaA Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 51. Astellas Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 52. Janssen Biotech Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
